Get access

Cognitive-behavioral therapy for bipolar disorders in adolescents: a pilot study

Authors


  • RF receives research support from Abbott Laboratories, AstraZeneca, Best Practices, Bristol-Myers Squibb, Celltech-Medeva, Forest, GlaxoSmithKline, Johnson & Johnson, Layton Biosciences, Eli Lilly & Co., Nature's Herbs, Novartis, Organon, Otsuka, Pfizer, Shire, Solvay, Somerset and Wyeth; is a consultant for Abbott Laboratories, AstraZeneca, Best Practices, Bristol-Myers Squibb, Celltech-Medeva, Forest, GlaxoSmithKline, Johnson & Johnson, Eli Lilly & Co., Novartis, Noven, Otsuka, Pfizer, Shire, Somerset and Wyeth; and serves on the speakers bureau for Abbott Laboratories, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Johnson & Johnson, Eli Lilly & Co., Otsuka, Shire and Wyeth. NCF, CKD, LS and EAY have no reported conflict of interest.

Norah C Feeny PhD, Department of Psychiatry, Case Western Reserve University School of Medicine and University Hospitals of Cleveland, 11100 Euclid Ave., Hanna Pavilion, Cleveland, OH 44106, USA.
Fax: +1 216 844 5883;
e-mail: norah.feeny@case.edu

Abstract

Objectives:  To develop a cognitive behavioral intervention for adolescents with bipolar disorders, test its feasibility and preliminary efficacy.

Methods:  Based on existing research, a manualized, individually delivered cognitive behavioral intervention was developed and tested with adolescents with bipolar disorders as an adjunct to pharmacological treatment. Using existing data, baseline characteristics and outcome were compared to a matched group of eight adolescents with bipolar disorders who did not receive any psychosocial intervention.

Results:  Preliminary results support the feasibility and efficacy of this manualized cognitive behavioral intervention.

Conclusions:  Individually delivered cognitive-behavioral therapy (CBT) as an adjunct to pharmacological treatment is feasible and associated with symptom improvement in adolescents with bipolar disorders. Randomized controlled studies are needed.

Ancillary